The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Mammalian Cell Expression System Market Research Report 2025
Synopsis
Mammalian cell expression system is a type of recombinant protein expression system that uses genetically modified mammalian cells to produce large amounts of specific proteins. Mammalian cells are a popular choice for protein expression because they have the ability to perform post-translational modifications such as glycosylation, phosphorylation, and disulfide bond formation, which are important for the biological activity and stability of many proteins. Mammalian cell expression systems are widely used in the production of recombinant proteins for research, therapeutic, and industrial applications. They offer high protein expression levels, produce proteins with correct post-translational modifications, and are suitable for the production of complex and difficult-to-express proteins.
Global Mammalian Cell Expression System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Mammalian Cell Expression System market research.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 314%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Mammalian Cell Expression System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Bio Basic
GenScript Biotech
Oxford Expression Technologies
ProteoGenix
Promab Biotechnologies
MTIBIO
AMSBIO
Kemp Proteins
Takara Bio
Genosphere Biotechnologies
Biocompare
Profacgen
Creative BioMart
Sino Biological
Hangzhou Clongene Biotech
Segment by Type
Chinese Hamster Ovary (CHO) Cells
Human Embryonic Kidney (HEK) Cells
Mouse Myeloma Cells
BHK-21 Cells
Others
Segment by Application
Drugs Development
Biomedical Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Mammalian Cell Expression System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Mammalian cell expression system is a type of recombinant protein expression system that uses genetically modified mammalian cells to produce large amounts of specific proteins. Mammalian cells are a popular choice for protein expression because they have the ability to perform post-translational modifications such as glycosylation, phosphorylation, and disulfide bond formation, which are important for the biological activity and stability of many proteins. Mammalian cell expression systems are widely used in the production of recombinant proteins for research, therapeutic, and industrial applications. They offer high protein expression levels, produce proteins with correct post-translational modifications, and are suitable for the production of complex and difficult-to-express proteins.
Global Mammalian Cell Expression System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Mammalian Cell Expression System market research.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 314%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Mammalian Cell Expression System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Bio Basic
GenScript Biotech
Oxford Expression Technologies
ProteoGenix
Promab Biotechnologies
MTIBIO
AMSBIO
Kemp Proteins
Takara Bio
Genosphere Biotechnologies
Biocompare
Profacgen
Creative BioMart
Sino Biological
Hangzhou Clongene Biotech
Segment by Type
Chinese Hamster Ovary (CHO) Cells
Human Embryonic Kidney (HEK) Cells
Mouse Myeloma Cells
BHK-21 Cells
Others
Segment by Application
Drugs Development
Biomedical Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Mammalian Cell Expression System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mammalian Cell Expression System Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chinese Hamster Ovary (CHO) Cells
1.2.3 Human Embryonic Kidney (HEK) Cells
1.2.4 Mouse Myeloma Cells
1.2.5 BHK-21 Cells
1.2.6 Others
1.3 Market by Application
1.3.1 Global Mammalian Cell Expression System Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drugs Development
1.3.3 Biomedical Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mammalian Cell Expression System Market Perspective (2018-2029)
2.2 Mammalian Cell Expression System Growth Trends by Region
2.2.1 Global Mammalian Cell Expression System Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Mammalian Cell Expression System Historic Market Size by Region (2018-2023)
2.2.3 Mammalian Cell Expression System Forecasted Market Size by Region (2024-2029)
2.3 Mammalian Cell Expression System Market Dynamics
2.3.1 Mammalian Cell Expression System Industry Trends
2.3.2 Mammalian Cell Expression System Market Drivers
2.3.3 Mammalian Cell Expression System Market Challenges
2.3.4 Mammalian Cell Expression System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mammalian Cell Expression System Players by Revenue
3.1.1 Global Top Mammalian Cell Expression System Players by Revenue (2018-2023)
3.1.2 Global Mammalian Cell Expression System Revenue Market Share by Players (2018-2023)
3.2 Global Mammalian Cell Expression System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mammalian Cell Expression System Revenue
3.4 Global Mammalian Cell Expression System Market Concentration Ratio
3.4.1 Global Mammalian Cell Expression System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mammalian Cell Expression System Revenue in 2022
3.5 Mammalian Cell Expression System Key Players Head office and Area Served
3.6 Key Players Mammalian Cell Expression System Product Solution and Service
3.7 Date of Enter into Mammalian Cell Expression System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mammalian Cell Expression System Breakdown Data by Type
4.1 Global Mammalian Cell Expression System Historic Market Size by Type (2018-2023)
4.2 Global Mammalian Cell Expression System Forecasted Market Size by Type (2024-2029)
5 Mammalian Cell Expression System Breakdown Data by Application
5.1 Global Mammalian Cell Expression System Historic Market Size by Application (2018-2023)
5.2 Global Mammalian Cell Expression System Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Mammalian Cell Expression System Market Size (2018-2029)
6.2 North America Mammalian Cell Expression System Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Mammalian Cell Expression System Market Size by Country (2018-2023)
6.4 North America Mammalian Cell Expression System Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mammalian Cell Expression System Market Size (2018-2029)
7.2 Europe Mammalian Cell Expression System Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Mammalian Cell Expression System Market Size by Country (2018-2023)
7.4 Europe Mammalian Cell Expression System Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mammalian Cell Expression System Market Size (2018-2029)
8.2 Asia-Pacific Mammalian Cell Expression System Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Mammalian Cell Expression System Market Size by Region (2018-2023)
8.4 Asia-Pacific Mammalian Cell Expression System Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mammalian Cell Expression System Market Size (2018-2029)
9.2 Latin America Mammalian Cell Expression System Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Mammalian Cell Expression System Market Size by Country (2018-2023)
9.4 Latin America Mammalian Cell Expression System Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mammalian Cell Expression System Market Size (2018-2029)
10.2 Middle East & Africa Mammalian Cell Expression System Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Mammalian Cell Expression System Market Size by Country (2018-2023)
10.4 Middle East & Africa Mammalian Cell Expression System Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Mammalian Cell Expression System Introduction
11.1.4 Thermo Fisher Scientific Revenue in Mammalian Cell Expression System Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Bio Basic
11.2.1 Bio Basic Company Detail
11.2.2 Bio Basic Business Overview
11.2.3 Bio Basic Mammalian Cell Expression System Introduction
11.2.4 Bio Basic Revenue in Mammalian Cell Expression System Business (2018-2023)
11.2.5 Bio Basic Recent Development
11.3 GenScript Biotech
11.3.1 GenScript Biotech Company Detail
11.3.2 GenScript Biotech Business Overview
11.3.3 GenScript Biotech Mammalian Cell Expression System Introduction
11.3.4 GenScript Biotech Revenue in Mammalian Cell Expression System Business (2018-2023)
11.3.5 GenScript Biotech Recent Development
11.4 Oxford Expression Technologies
11.4.1 Oxford Expression Technologies Company Detail
11.4.2 Oxford Expression Technologies Business Overview
11.4.3 Oxford Expression Technologies Mammalian Cell Expression System Introduction
11.4.4 Oxford Expression Technologies Revenue in Mammalian Cell Expression System Business (2018-2023)
11.4.5 Oxford Expression Technologies Recent Development
11.5 ProteoGenix
11.5.1 ProteoGenix Company Detail
11.5.2 ProteoGenix Business Overview
11.5.3 ProteoGenix Mammalian Cell Expression System Introduction
11.5.4 ProteoGenix Revenue in Mammalian Cell Expression System Business (2018-2023)
11.5.5 ProteoGenix Recent Development
11.6 Promab Biotechnologies
11.6.1 Promab Biotechnologies Company Detail
11.6.2 Promab Biotechnologies Business Overview
11.6.3 Promab Biotechnologies Mammalian Cell Expression System Introduction
11.6.4 Promab Biotechnologies Revenue in Mammalian Cell Expression System Business (2018-2023)
11.6.5 Promab Biotechnologies Recent Development
11.7 MTIBIO
11.7.1 MTIBIO Company Detail
11.7.2 MTIBIO Business Overview
11.7.3 MTIBIO Mammalian Cell Expression System Introduction
11.7.4 MTIBIO Revenue in Mammalian Cell Expression System Business (2018-2023)
11.7.5 MTIBIO Recent Development
11.8 AMSBIO
11.8.1 AMSBIO Company Detail
11.8.2 AMSBIO Business Overview
11.8.3 AMSBIO Mammalian Cell Expression System Introduction
11.8.4 AMSBIO Revenue in Mammalian Cell Expression System Business (2018-2023)
11.8.5 AMSBIO Recent Development
11.9 Kemp Proteins
11.9.1 Kemp Proteins Company Detail
11.9.2 Kemp Proteins Business Overview
11.9.3 Kemp Proteins Mammalian Cell Expression System Introduction
11.9.4 Kemp Proteins Revenue in Mammalian Cell Expression System Business (2018-2023)
11.9.5 Kemp Proteins Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Detail
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio Mammalian Cell Expression System Introduction
11.10.4 Takara Bio Revenue in Mammalian Cell Expression System Business (2018-2023)
11.10.5 Takara Bio Recent Development
11.11 Genosphere Biotechnologies
11.11.1 Genosphere Biotechnologies Company Detail
11.11.2 Genosphere Biotechnologies Business Overview
11.11.3 Genosphere Biotechnologies Mammalian Cell Expression System Introduction
11.11.4 Genosphere Biotechnologies Revenue in Mammalian Cell Expression System Business (2018-2023)
11.11.5 Genosphere Biotechnologies Recent Development
11.12 Biocompare
11.12.1 Biocompare Company Detail
11.12.2 Biocompare Business Overview
11.12.3 Biocompare Mammalian Cell Expression System Introduction
11.12.4 Biocompare Revenue in Mammalian Cell Expression System Business (2018-2023)
11.12.5 Biocompare Recent Development
11.13 Profacgen
11.13.1 Profacgen Company Detail
11.13.2 Profacgen Business Overview
11.13.3 Profacgen Mammalian Cell Expression System Introduction
11.13.4 Profacgen Revenue in Mammalian Cell Expression System Business (2018-2023)
11.13.5 Profacgen Recent Development
11.14 Creative BioMart
11.14.1 Creative BioMart Company Detail
11.14.2 Creative BioMart Business Overview
11.14.3 Creative BioMart Mammalian Cell Expression System Introduction
11.14.4 Creative BioMart Revenue in Mammalian Cell Expression System Business (2018-2023)
11.14.5 Creative BioMart Recent Development
11.15 Sino Biological
11.15.1 Sino Biological Company Detail
11.15.2 Sino Biological Business Overview
11.15.3 Sino Biological Mammalian Cell Expression System Introduction
11.15.4 Sino Biological Revenue in Mammalian Cell Expression System Business (2018-2023)
11.15.5 Sino Biological Recent Development
11.16 Hangzhou Clongene Biotech
11.16.1 Hangzhou Clongene Biotech Company Detail
11.16.2 Hangzhou Clongene Biotech Business Overview
11.16.3 Hangzhou Clongene Biotech Mammalian Cell Expression System Introduction
11.16.4 Hangzhou Clongene Biotech Revenue in Mammalian Cell Expression System Business (2018-2023)
11.16.5 Hangzhou Clongene Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
